This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Amgen Inc., Cytokinetics, Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 2,077 
1 out of 261 
Years Active: 2022-2026
Title: Lingyun Xiao: Innovator in Pharmaceutical Patents
Introduction
Lingyun Xiao is a prominent inventor based in Thousand Oaks, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on omecamtiv mecarbil. With a total of 3 patents, her research has the potential to impact the treatment of various medical conditions.
Latest Patents
Lingyun Xiao's latest patents focus on the salts and crystal forms of omecamtiv mecarbil. The patents provide detailed descriptions of free base crystalline forms, crystalline salts, and amorphous salts of this compound. These innovations are crucial for enhancing the efficacy and stability of the drug.
Career Highlights
Throughout her career, Lingyun has worked with leading companies in the pharmaceutical industry, including Amgen Inc. and Cytokinetics, Inc. Her experience in these organizations has allowed her to develop her expertise and contribute to groundbreaking research.
Collaborations
Lingyun has collaborated with notable colleagues such as Henry Morrison and Sheng Cui. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Lingyun Xiao's contributions to the field of pharmaceuticals through her patents on omecamtiv mecarbil demonstrate her commitment to advancing medical science. Her work continues to inspire future innovations in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile